Abstract
Background Spontaneous reporting of suspected adverse drug events (ADEs) by health professionals is a cornerstone in pharmacovigilance and an important source from which to generate new adverse drug reaction (ADR) signals. However, under-reporting is a major challenge.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
